PLNH · Planet 13 Holdings Inc.
Market Cap
$34.20M
Shares
335.32M
Volume · Oct 19
271.99K
Avg daily vol (3M)
371.56K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.10
Open$0.11
Day$0.10–0.11
52W close$0.10–0.35
Avg vol 30d285K
Short int569K · 0.2% float · 1.0d
Short vol47%
Last earningsAug 12, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 12
Up next
Next earnings call
Nov 11, 2026
Est · unconfirmed
· in 3 wks
filed Aug 12, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$92.44M
Trailing 12 months
Net income (TTM)
−$62.26M
Trailing 12 months
Revenue growth YoY
-14.9%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-28.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$4.43M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+7.8%
Year over year · more shares
Price change (1Y)
-51.8%
Trailing year
Short interest
0.2%
Latest settlement · 1.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−30%
below
Price vs 50-day avg
−21%
below
RSI (14)
34
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−22%
trailing
6-month return
−32%
trailing
YTD return
−49%
this year
Relative strength
−40%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-20% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.17% of float · ▲ +143.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 3-yr range
Squeeze score
42
elevated · 0–100
Fundamentals
Revenue growth
−11%
Y/Y
Gross margin
39%
contracting
Free cash flow
$-20.8M
Balance sheet
$5.7M
net debt
Quant / Vol
risk profile
Volatility
116%
annualized · 1-yr
Max drawdown
−71%
past year
ATR
10.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−30%
Bearish
Price vs 50-day avg
−21%
Bearish
RSI (14)
34
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-20% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.17% of float · ▲ +143.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $0
vs 200-day avg -30%
vs 50-day avg -21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $0.5M | Q2 2026 | — |
| Adjusted EBITDA Margin % non-GAAP | -2.3% | Q2 2026 | — |
| Gross Profit Margin % | 53.9% | Three Months Ended June 30, 2026 filing | — |
| Weighted Average Number of Shares Outstanding, Basic and diluted | 330,658,007 | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PLNH
this stock
Planet 13 Holdings Inc.
|
$34.20M | -49.2% | -11.2% | — | 0.2% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$62.65B | +28.8% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$48.88B | +1.1% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$48.14B | +30.9% | +4.3% | 67.7 | 2.6% |
|
HLN
Haleon plc
|
$44.72B | +0.6% | — | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
4
- % held
- 0.0%
- Net QoQ
- -20 sh
- Top holder
- Front Row Advisors LLC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PLNH | -6.3% | -22.1% | -31.9% | -9.2% | -49.2% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -4.8% | -21.2% | -39.6% | -9.7% | -61.6% |